Frontiers in Medicine (Apr 2022)

Health-Related Quality of Life Evaluation Using the Short Form-36 in Patients With Human T-Lymphotropic Virus Type 1-Associated Myelopathy

  • Miyuna Kimura,
  • Miyuna Kimura,
  • Junji Yamauchi,
  • Junji Yamauchi,
  • Tomoo Sato,
  • Tomoo Sato,
  • Naoko Yagishita,
  • Natsumi Araya,
  • Satoko Aratani,
  • Satoko Aratani,
  • Kenichiro Tanabe,
  • Erika Horibe,
  • Toshiki Watanabe,
  • Ariella Coler-Reilly,
  • Misako Nagasaka,
  • Misako Nagasaka,
  • Yukari Akasu,
  • Kei Kaburagi,
  • Takayuki Kikuchi,
  • Soichiro Shibata,
  • Hirofumi Matsumoto,
  • Akihito Koseki,
  • Akihito Koseki,
  • Soichiro Inoue,
  • Ayako Takata,
  • Yoshihisa Yamano,
  • Yoshihisa Yamano

DOI
https://doi.org/10.3389/fmed.2022.879379
Journal volume & issue
Vol. 9

Abstract

Read online

BackgroundHuman T-lymphotropic virus type 1 (HTLV-1)-associated myelopathy (HAM) is a neuroinflammatory disease, causing various neurological symptoms, including motor, sensory, and bladder and bowel dysfunctions. This study was designed to reveal the impact of HAM and related symptoms on health-related quality of life (HRQoL).MethodsWe analyzed the Short Form-36 (SF-36) and clinical data of 538 patients with HAM registered in the HAM-net, a nationwide patient registry for HAM in Japan. HRQoL was evaluated using the SF-6D (a health state utility value calculated from the SF-36) and eight SF-36 subscales. A general liner model was used to estimate the impact of major HAM-related symptoms, including gait dysfunction, sensory disturbance in the legs (pain and numbness), urinary dysfunction, and constipation, on the SF-6D and SF-36 subscale scores.ResultsThe mean age and disease duration were 62.0 and 16.5 years, respectively. Of the patients, 73.2% needed walking aid; 42.7 and 67.1% had leg pain and numbness, respectively; 92.1% had urinary dysfunction; and 77.9% had constipation. The mean SF-6D score was 0.565, which was significantly lower than the national average (0.674 in the 60–69 years age group; p < 0.001), exceeding the minimal important difference (0.05–0.1). All the major symptoms were significantly associated with a decrease in the SF-6D score. The SF-36 subscale scores were significantly lower than the national standard of 50 (p ≤ 0.001), except for mental health (MH). Gait dysfunction was associated with lower scores in physical functioning (PF), limitations on role functioning because of physical health, bodily pain, general health perception (GH), vitality (VT), and social functioning; however, no association was observed between gait dysfunction and limitations on role functioning because of emotional problems and MH. Meanwhile, sensory disturbance in the legs was associated with a decrease in scores in all subscales. Urinary dysfunction was associated with worse PF, GH, VT, and MH. Constipation was associated only with PF.ConclusionHRQoL of patients with HAM was worse than that of the general population and was associated with all major symptoms. Thus, patients should be comprehensively managed to achieve better HRQoL.

Keywords